László Offertáler

3.8k total citations · 2 hit papers
14 papers, 3.0k citations indexed

About

László Offertáler is a scholar working on Pharmacology, Endocrine and Autonomic Systems and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, László Offertáler has authored 14 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 5 papers in Endocrine and Autonomic Systems and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in László Offertáler's work include Cannabis and Cannabinoid Research (13 papers), Diet, Metabolism, and Disease (5 papers) and Neuroscience of respiration and sleep (5 papers). László Offertáler is often cited by papers focused on Cannabis and Cannabinoid Research (13 papers), Diet, Metabolism, and Disease (5 papers) and Neuroscience of respiration and sleep (5 papers). László Offertáler collaborates with scholars based in United States, Israel and Palestinian Territory. László Offertáler's co-authors include George Kunos, Pál Pacher, Douglas Osei‐Hyiaman, Sándor Bátkai, Judith Harvey‐White, Ken Mackie, Svetlana Radaeva, Jie Liu, Lei Wang and Michael A. DePetrillo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

László Offertáler

14 papers receiving 3.0k citations

Hit Papers

Endocannabinoid activation at hepatic CB1 receptors stimu... 2005 2026 2012 2019 2005 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
    2005 840 citations Douglas Osei‐Hyiaman, Michael A. DePetrillo et al. Journal of Clinical Investigation profile →
  2. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
    2005 788 citations Douglas Osei‐Hyiaman, Michael A. DePetrillo et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Offertáler United States 14 2.5k 1.1k 720 643 554 14 3.0k
Raquel Gómez de Heras Spain 20 1.5k 0.6× 583 0.5× 897 1.2× 499 0.8× 441 0.8× 37 2.6k
Michael A. DePetrillo United States 6 1.3k 0.5× 786 0.7× 265 0.4× 545 0.8× 425 0.8× 7 1.9k
Fariba Oveisi United States 25 1.3k 0.5× 785 0.7× 336 0.5× 1.3k 2.0× 527 1.0× 38 3.7k
Jesse LoVerme United States 11 1.2k 0.5× 273 0.2× 411 0.6× 428 0.7× 252 0.5× 12 1.7k
Colin Stott United Kingdom 18 1.8k 0.7× 352 0.3× 598 0.8× 178 0.3× 208 0.4× 26 2.4k
Jean Marchand France 7 1.9k 0.8× 224 0.2× 935 1.3× 294 0.5× 292 0.5× 15 2.1k
Barbara Malinowska Poland 27 1.0k 0.4× 365 0.3× 591 0.8× 376 0.6× 129 0.2× 120 2.3k
Christen M. Anderson United States 24 1.5k 0.6× 1.3k 1.1× 339 0.5× 1.1k 1.7× 371 0.7× 31 3.5k
Tiziano Croci Italy 27 691 0.3× 302 0.3× 688 1.0× 557 0.9× 185 0.3× 62 2.1k
Susan M. Huang United States 15 1.5k 0.6× 188 0.2× 925 1.3× 576 0.9× 139 0.3× 18 2.3k

Countries citing papers authored by László Offertáler

Since Specialization
Citations

This map shows the geographic impact of László Offertáler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Offertáler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Offertáler more than expected).

Fields of papers citing papers by László Offertáler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Offertáler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Offertáler. The network helps show where László Offertáler may publish in the future.

Co-authorship network of co-authors of László Offertáler

This figure shows the co-authorship network connecting the top 25 collaborators of László Offertáler. A scholar is included among the top collaborators of László Offertáler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Offertáler. László Offertáler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Godlewski, Grzegorz, Shakiru O. Alapafuja, Sándor Bátkai, et al.. (2010). Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects. Chemistry & Biology. 17(11). 1256–1266. 83 indexed citations
2.
Godlewski, Grzegorz, László Offertáler, Jens A. Wagner, & George Kunos. (2009). Receptors for acylethanolamides—GPR55 and GPR119. Prostaglandins & Other Lipid Mediators. 89(3-4). 105–111. 194 indexed citations
3.
Turu, Gábor, Péter Várnai, László Szidonya, et al.. (2009). Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled Receptors. Journal of Biological Chemistry. 284(25). 16914–16921. 54 indexed citations
4.
Godlewski, Grzegorz, László Offertáler, Douglas Osei‐Hyiaman, et al.. (2008). The Endogenous Brain Constituent N-Arachidonoyl l-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels. Journal of Pharmacology and Experimental Therapeutics. 328(1). 351–361. 34 indexed citations
5.
Milman, Garry, Yehoshua Maor, Saleh Abu‐Lafi, et al.. (2006). N-arachidonoyll-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proceedings of the National Academy of Sciences. 103(7). 2428–2433. 143 indexed citations
6.
Osei‐Hyiaman, Douglas, Michael A. DePetrillo, Pál Pacher, et al.. (2005). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation. 115(5). 1298–1305. 840 indexed citations breakdown →
7.
Pacher, Pál, Sándor Bátkai, Douglas Osei‐Hyiaman, et al.. (2005). Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. American Journal of Physiology-Heart and Circulatory Physiology. 289(2). H533–H541. 71 indexed citations
8.
Begg, Malcolm, Pál Pacher, Douglas Osei‐Hyiaman, et al.. (2005). Evidence for novel cannabinoid receptors. Pharmacology & Therapeutics. 106(2). 133–145. 311 indexed citations
9.
Osei‐Hyiaman, Douglas, Michael A. DePetrillo, Pál Pacher, et al.. (2005). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation. 115(5). 1298–1305. 788 indexed citations breakdown →
10.
Offertáler, László, et al.. (2004). Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. European Journal of Pharmacology. 489(1-2). 21–27. 56 indexed citations
11.
Bátkai, Sándor, Pál Pacher, Douglas Osei‐Hyiaman, et al.. (2004). Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension. Circulation. 110(14). 1996–2002. 277 indexed citations
12.
Begg, Malcolm, László Offertáler, Sándor Bátkai, et al.. (2003). G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current. Journal of Biological Chemistry. 278(46). 46188–46194. 75 indexed citations
13.
Kunos, George, et al.. (2002). The quest for a vascular endothelial cannabinoid receptor. Chemistry and Physics of Lipids. 121(1-2). 45–56. 37 indexed citations
14.
Bukoski, Richard D., Sándor Bátkai, Zoltán Járai, et al.. (2002). CB 1 Receptor Antagonist SR141716A Inhibits Ca 2+ -Induced Relaxation in CB 1 Receptor-Deficient Mice. Hypertension. 39(2). 251–257. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel Gómez de Heras Breakdown of academic impact, for papers by Michael A. DePetrillo Breakdown of academic impact, for papers by Fariba Oveisi Breakdown of academic impact, for papers by Jesse LoVerme Breakdown of academic impact, for papers by Colin Stott Breakdown of academic impact, for papers by Jean Marchand Breakdown of academic impact, for papers by Barbara Malinowska Breakdown of academic impact, for papers by Christen M. Anderson Breakdown of academic impact, for papers by Tiziano Croci Breakdown of academic impact, for papers by Susan M. Huang
Rankless by CCL
2026